The treat-to-target approach has been a major breakthrough in the treatment of rheumatoid arthritis. Although this strategy has been evaluated in many clinical studies, whether a high level of adherence is feasible in real-world clinical practice remains uncertain.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
McInnes, I. B. & O'Dell, J. R. State-of-the art: rheumatoid arthritis. Ann. Rheum. Dis. 69, 1898–1906 (2010).
Vermeer, M. et al. Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission cohort. Arthritis Res. Ther. 14, R254 (2012).
Akhavan, P. et al. Discrepancy between patient and physician global assessments over time in early rheumatoid arthritis [abstract 2109]. Arthritis Rheum. 64 (Suppl.), S892 (2012).
Wolfe, F., Michaud, K., Pincus, T., Furst, D. & Keystone, E. The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti–tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposes. Arthritis Rheum. 52, 3873–3879 (2005).
Pyne, L. et al. Increasing treatment in early rheumatoid arthritis is not determined by the disease activity score but by physician global assessment: results from the CATCH study. J. Rheum. 39, 2081–2087 (2012).
Akhavan, P. et al. Patients with early rheumatoid arthritis determined to be inadequate responders after 12 weeks may still have substantial improvement in core set measures. Results from an early arthritis cohort [abstract 339]. Arthritis Rheum. 63 (Suppl.), S127 (2011).
Akhavan, P. et al. Three months of therapy with DMARDs is an inadequate period of time to alter the treatment in patients with early rheumatoid arthritis when treating to a target of low disease state or remission. Results from Canadian Early Arthritis CoHort (CATCH) [abstract 343]. Arthritis Rheum. 62 (Suppl.), S144 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Cohen, M., Keystone, E. Issues in implementing a treat-to-target approach in RA. Nat Rev Rheumatol 9, 137–138 (2013). https://doi.org/10.1038/nrrheum.2013.18
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2013.18
